Kalvista Pharmaceuticals Stock Earnings Per Share
| KALV Stock | USD 11.35 0.34 3.09% |
Kalvista Pharmaceuticals fundamentals help investors to digest information that contributes to Kalvista Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Kalvista Stock. The fundamental analysis module provides a way to measure Kalvista Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kalvista Pharmaceuticals stock.
Kalvista | Earnings Per Share |
Kalvista Pharmaceuticals Company Earnings Per Share Analysis
Kalvista Pharmaceuticals' Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Kalvista Pharmaceuticals Earnings Per Share | (3.12) X |
Most of Kalvista Pharmaceuticals' fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kalvista Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Kalvista Earnings Per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for Kalvista Pharmaceuticals is extremely important. It helps to project a fair market value of Kalvista Stock properly, considering its historical fundamentals such as Earnings Per Share. Since Kalvista Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Kalvista Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Kalvista Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
Kalvista Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
According to the company disclosure, Kalvista Pharmaceuticals has an Earnings Per Share of -3.12 times. This is 137.28% lower than that of the Biotechnology sector and 34.86% lower than that of the Health Care industry. The earnings per share for all United States stocks is 200.0% higher than that of the company.
Kalvista Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kalvista Pharmaceuticals' direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kalvista Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Kalvista Pharmaceuticals by comparing valuation metrics of similar companies.Kalvista Pharmaceuticals is currently under evaluation in earnings per share category among related companies.
Kalvista Fundamentals
| Return On Equity | -0.79 | ||||
| Return On Asset | -0.42 | ||||
| Current Valuation | 396.35 M | ||||
| Shares Outstanding | 42.19 M | ||||
| Shares Owned By Insiders | 1.14 % | ||||
| Shares Owned By Institutions | 93.70 % | ||||
| Number Of Shares Shorted | 5.82 M | ||||
| Price To Earning | (2.82) X | ||||
| Price To Book | 5.66 X | ||||
| Price To Sales | 107.42 X | ||||
| Gross Profit | (80.28 M) | ||||
| EBITDA | (110.24 M) | ||||
| Net Income | (92.91 M) | ||||
| Cash And Equivalents | 142.08 M | ||||
| Cash Per Share | 5.78 X | ||||
| Total Debt | 8.23 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 17.51 X | ||||
| Book Value Per Share | 2.56 X | ||||
| Cash Flow From Operations | (75.26 M) | ||||
| Short Ratio | 10.49 X | ||||
| Earnings Per Share | (3.12) X | ||||
| Target Price | 30.6 | ||||
| Number Of Employees | 118 | ||||
| Beta | 0.91 | ||||
| Market Capitalization | 469.98 M | ||||
| Total Asset | 183.2 M | ||||
| Retained Earnings | (343.08 M) | ||||
| Working Capital | 157.29 M | ||||
| Current Asset | 54.95 M | ||||
| Current Liabilities | 4.27 M | ||||
| Net Asset | 183.2 M |
About Kalvista Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kalvista Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kalvista Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kalvista Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Kalvista Pharmaceuticals Piotroski F Score and Kalvista Pharmaceuticals Altman Z Score analysis. For more information on how to buy Kalvista Stock please use our How to Invest in Kalvista Pharmaceuticals guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Kalvista Stock analysis
When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Kalvista Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kalvista Pharmaceuticals. If investors know Kalvista will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kalvista Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.12) | Revenue Per Share 0.214 | Quarterly Revenue Growth 0.307 | Return On Assets (0.42) | Return On Equity (0.79) |
The market value of Kalvista Pharmaceuticals is measured differently than its book value, which is the value of Kalvista that is recorded on the company's balance sheet. Investors also form their own opinion of Kalvista Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kalvista Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kalvista Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kalvista Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kalvista Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kalvista Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kalvista Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.